tiprankstipranks
Trending News
More News >
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
US Market

Interpace Diagnostics Group (IDXG) Ratios

Compare
413 Followers

Interpace Diagnostics Group Ratios

IDXG's free cash flow for Q3 2025 was $0.62. For the 2025 fiscal year, IDXG's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Mar 22
Liquidity Ratios
Current Ratio
1.54 1.11 0.59 0.85 0.78
Quick Ratio
1.54 1.00 0.52 0.77 0.66
Cash Ratio
0.24 0.14 0.20 0.34 0.21
Solvency Ratio
0.45 0.44 0.06 -0.04 -0.12
Operating Cash Flow Ratio
0.82 0.44 0.22 -0.54 -0.56
Short-Term Operating Cash Flow Coverage
4.99 1.08 0.74 -3.08 0.00
Net Current Asset Value
$ -3.20M$ -5.24M$ -17.84M$ -66.90M$ -68.68M
Leverage Ratios
Debt-to-Assets Ratio
0.19 0.40 0.86 1.01 0.36
Debt-to-Equity Ratio
-7.58 -2.64 -0.74 -0.26 -0.32
Debt-to-Capital Ratio
1.15 1.61 -2.84 -0.34 -0.48
Long-Term Debt-to-Capital Ratio
0.00 0.00 -0.39 -0.22 -0.29
Financial Leverage Ratio
-40.39 -6.67 -0.86 -0.25 -0.91
Debt Service Coverage Ratio
4.76 1.69 0.63 -0.65 -0.64
Interest Coverage Ratio
20.81 12.30 2.78 -3.81 -11.29
Debt to Market Cap
0.13 0.36 2.00 3.10 0.31
Interest Debt Per Share
0.57 1.49 2.83 4.03 3.57
Net Debt to EBITDA
0.14 0.53 2.01 -4.97 -7.83
Profitability Margins
Gross Profit Margin
64.57%63.77%59.44%57.26%43.44%
EBIT Margin
12.78%16.21%6.99%-15.16%-16.22%
EBITDA Margin
14.48%17.81%9.54%-7.12%-3.21%
Operating Profit Margin
13.34%17.28%6.97%-12.06%-28.41%
Pretax Profit Margin
12.47%14.81%2.81%-18.33%-37.31%
Net Profit Margin
11.50%14.28%1.99%-18.42%-35.69%
Continuous Operations Profit Margin
12.21%14.80%2.77%-18.42%-17.03%
Net Income Per EBT
92.25%96.43%71.04%100.50%95.67%
EBT Per EBIT
93.47%85.72%40.26%151.98%131.32%
Return on Assets (ROA)
39.96%45.31%6.16%-36.70%-38.37%
Return on Equity (ROE)
-446.40%-302.30%-5.30%9.30%34.76%
Return on Capital Employed (ROCE)
91.58%194.11%-62.97%-226.42%-51.60%
Return on Invested Capital (ROIC)
72.67%91.56%269.70%-80.44%-47.77%
Return on Tangible Assets
39.96%45.31%6.16%-38.79%-64.94%
Earnings Yield
63.48%56.58%17.20%-133.07%-47.74%
Efficiency Ratios
Receivables Turnover
7.01 5.49 8.07 6.33 8.84
Payables Turnover
10.50 10.25 10.56 12.96 17.01
Inventory Turnover
0.00 14.04 13.29 11.12 13.08
Fixed Asset Turnover
14.62 15.78 15.15 10.91 3.98
Asset Turnover
3.47 3.17 3.09 1.99 1.08
Working Capital Turnover Ratio
15.10 -15.66 -8.67 -11.28 -10.83
Cash Conversion Cycle
17.31 56.84 38.13 62.36 47.71
Days of Sales Outstanding
52.07 66.46 45.23 57.69 41.28
Days of Inventory Outstanding
0.00 26.00 27.46 32.83 27.90
Days of Payables Outstanding
34.76 35.62 34.55 28.17 21.46
Operating Cycle
52.07 92.46 72.69 90.52 69.17
Cash Flow Ratios
Operating Cash Flow Per Share
1.10 1.06 0.88 -1.82 -2.11
Free Cash Flow Per Share
1.00 0.86 0.77 -1.89 -2.19
CapEx Per Share
0.10 0.20 0.11 0.08 0.09
Free Cash Flow to Operating Cash Flow
0.91 0.81 0.88 1.04 1.04
Dividend Paid and CapEx Coverage Ratio
10.91 5.30 8.06 -23.89 -24.63
Capital Expenditure Coverage Ratio
10.91 5.30 8.06 -23.89 -24.63
Operating Cash Flow Coverage Ratio
2.16 0.79 0.34 -0.48 -0.64
Operating Cash Flow to Sales Ratio
0.12 0.10 0.09 -0.24 -0.21
Free Cash Flow Yield
58.42%31.83%71.19%-181.83%-29.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.58 1.77 5.81 -0.75 -2.09
Price-to-Sales (P/S) Ratio
0.18 0.25 0.12 0.14 0.75
Price-to-Book (P/B) Ratio
-25.43 -5.34 -0.31 -0.07 -0.73
Price-to-Free Cash Flow (P/FCF) Ratio
1.71 3.14 1.40 -0.55 -3.40
Price-to-Operating Cash Flow Ratio
1.55 2.55 1.23 -0.57 -3.54
Price-to-Earnings Growth (PEG) Ratio
-0.23 <0.01 -0.05 0.01 0.05
Price-to-Fair Value
-25.43 -5.34 -0.31 -0.07 -0.73
Enterprise Value Multiple
1.39 1.94 3.22 -6.91 -31.09
Enterprise Value
8.42M 16.24M 12.36M 15.67M 41.29M
EV to EBITDA
1.39 1.94 3.22 -6.91 -31.09
EV to Sales
0.20 0.35 0.31 0.49 1.00
EV to Free Cash Flow
1.90 4.31 3.72 -1.96 -4.55
EV to Operating Cash Flow
1.73 3.50 3.26 -2.04 -4.74
Tangible Book Value Per Share
-0.07 -0.51 -3.51 -15.09 -14.06
Shareholders’ Equity Per Share
-0.07 -0.51 -3.51 -14.88 -10.26
Tax and Other Ratios
Effective Tax Rate
0.02 <0.01 0.02 >-0.01 0.04
Revenue Per Share
9.45 10.70 9.32 7.51 9.99
Net Income Per Share
1.09 1.53 0.19 -1.38 -3.57
Tax Burden
0.92 0.96 0.71 1.00 0.96
Interest Burden
0.98 0.91 0.40 1.21 2.30
Research & Development to Revenue
0.02 0.01 0.02 0.02 0.05
SG&A to Revenue
0.24 0.20 0.23 0.34 0.33
Stock-Based Compensation to Revenue
<0.01 <0.01 0.02 0.04 0.03
Income Quality
1.25 0.69 4.72 0.35 0.58
Currency in USD